home.social

#sanofi — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #sanofi, aggregated by home.social.

fetched live
  1. Sanofi stock steadies as upgraded 2026 guidance follows strong Q2 momentum

    Sanofi stock is showing a steady tone in the latest session after the Paris-based drugmaker reported stronger Q2…
    #France #FR #Europe #EU #Sanofi #FR0000127771
    europesays.com/france/67461/

  2. Is Sanofi (ENXTPA:SAN) Reasonable After A 10% Three Year Slide?

    Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
    #France #FR #Europe #EU #Sanofi #Sanofistock
    europesays.com/france/67448/

  3. Enterprise lab-in-the-loop on AWS: How Sanofi is compressing drug discovery from years to weeks

    The pharmaceutical industry is racing to use AI for drug discovery, yet many organizations encounter the same invisible…
    #France #FR #Europe #EU #Sanofi
    europesays.com/france/67320/

  4. Sanofi reprimanded for disparaging Pfizer’s RSV vaccine

    A U.K. marketing watchdog has reprimanded Sanofi for using “a highly misleading interpretation of data” to make disparaging…
    #France #FR #Europe #EU #Sanofi #Abrysvo #Beyfortus #FiercePharmaHomepage #marketing #Pfizer #pharma #PMCPA #RSV
    europesays.com/france/67182/

  5. Sanofi gets FDA untitled letter over Beyfortus promotional emails

    The FDA has called out Sanofi’s promotion of respiratory syncytial virus (RSV) antibody Beyfortus in a new untitled…
    #France #FR #Europe #EU #Sanofi #Beyfortus #FDA #FiercePharmaHomepage #marketing #OPDP #untitledletter
    europesays.com/france/67163/

  6. New CEO Garijo sketches out vision to redirect Sanofi’s fortunes

    In her inaugural earnings call as the new CEO of Sanofi, Belén Garijo—until recently head honcho at Germany’s…
    #France #FR #Europe #EU #Sanofi #BelénGarijo #Dupixent #Earnings #FiercePharmaHomepage #PaulHudson #pharma #pharmaCEO #pipeline #Womenbiopharmaexecutives
    europesays.com/france/67148/

  7. Sanofi asked to change Dupixent ads after Galderma challenge

    Galderma Laboratories has landed a blow on Sanofi in its multi-case advertising row, driving the French drugmaker to change…
    #France #FR #Europe #EU #Sanofi #DTCadvertising #Dupixent #FiercePharmaHomepage #Galderma #marketing #NationalAdvertisingDivision #pharma
    europesays.com/france/67111/

  8. Sanofi and UNICEF Partner to Reach Unvaccinated Children in Eastern Cape

    Sanofi and the United Nations Children’s Fund (UNICEF) have partnered to improve access to childhood immunisation in three…
    #France #FR #Europe #EU #Sanofi #UNICEF
    europesays.com/france/67093/

  9. Sanofi Stock Analysis: Daily Trend Holds Despite Intraday Pressure

    SanDisk stock sits in a delicate spot. The daily chart still shows a broader uptrend, but the last…
    #France #FR #Europe #EU #Sanofi #stock
    europesays.com/france/67060/

  10. Sanofi (ENXTPA:SAN) On TD Cowen Spotlight And The Case For A Higher Valuation

    Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
    #France #FR #Europe #EU #Sanofi #Cowen #fairvalue #immunology #individualinvestors #rarediseases
    europesays.com/france/67000/

  11. Sanofi (ENXTPA:SAN) On TD Cowen Spotlight And The Case For A Higher Valuation

    Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
    #France #FR #Europe #EU #Sanofi #Cowen #fairvalue #immunology #individualinvestors #rarediseases
    europesays.com/france/66974/

  12. Sanofi Celebrates 35 Years of the Rare Humanitarian Program

    Sanofi shared on LinkedIn: “This year marks 35 years of our humanitarian commitment in rare diseases – more…
    #France #FR #Europe #EU #Sanofi
    europesays.com/france/66795/

  13. Sanofi (ENXTPA:SAN), Why Is This Fresh Development Drawing Attention?

    Sanofi (ENXTPA:SAN) is in focus after the European Commission approved an expanded indication for its MenQuadfi meningococcal vaccine,…
    #France #FR #Europe #EU #Sanofi
    europesays.com/france/66466/

  14. Nurix Therapeutics (NRIX) Starts Phase 3 And Lands Sanofi Milestone, Is The Valuation About Right?

    Nurix Therapeutics (NRIX) has drawn investor attention after two key events. The company reported a new Phase 3…
    #France #FR #Europe #EU #Sanofi
    europesays.com/france/66444/

  15. Sanofi stock trades around mid-August lows as Q2 2026 earnings and guidance frame a cautious outlook

    Sanofi (FR0000127771) stock is holding close to recent mid-August levels, with its US-listed shares last indicated at $43.72…
    #France #FR #Europe #EU #Sanofi #FR0000127771
    europesays.com/france/66342/

  16. Sanofi to lay off 229 workers in Mass.

    Sanofi, one of the state’s largest pharmaceutical employers, will lay off 229 workers, according to records the company…
    #France #FR #Europe #EU #Sanofi #07powerplay
    europesays.com/france/66332/

  17. Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition

    In the first major workforce reduction disclosed under new CEO Belén Garijo, Sanofi is laying off 229 employees…
    #France #FR #Europe #EU #Sanofi #BlueprintMedicines #Cambridge #FiercePharmaHomepage #jobcuts #layoffs #Massachusetts #pharma
    europesays.com/france/66324/

  18. Sanofi to lay off 229 Blueprint employees, close offices

    Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities.…
    #France #FR #Europe #EU #Sanofi
    europesays.com/france/66210/

  19. Nurix Therapeutics (NRIX) Is Up 6.0% After Milestone From Sanofi And Phase 3 Start With Roche

    Nurix Therapeutics recently reported earning a US$10 million milestone payment from Sanofi for advancing its oral STAT6 degrader…
    #France #FR #Europe #EU #Sanofi
    europesays.com/france/65878/

  20. Two Pompe Disease Treatments Are in Short Supply Weeks After Regulators Cited the Plant That Releases Them

    Patients with Pompe disease in the United States and Europe are reporting delayed shipments of the enzyme infusions…
    #France #FR #Europe #EU #Sanofi #enzymereplacementtherapy #Nexviazymesupply #Pompediseaseshortage #rarediseasedrugshortage #SanofiWaterfordplant
    europesays.com/france/65371/

  21. AlphaValue still cautious about Sanofi

    Sanofi stands out on the Paris stock market with a 0.94% gain, at EUR76.14. AlphaValue takes a close…
    #France #FR #Europe #EU #Sanofi #Markets
    europesays.com/france/65359/

  22. Sanofi: Information concerning the total number of voting rights and shares – July 2026

    Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of…
    #France #FR #Europe #EU #Sanofi #2026 #and #concerning #information #July #number #of #Rights #shares #the #Total #voting
    europesays.com/france/65348/

  23. Sanofi stock steadies as Sanofi India trades at 3,261.20

    Sanofi stock is anchored by Sanofi India at 3,261.20 rupees, up 0.39% as of August 14, 2026 at…
    #France #FR #Europe #EU #Sanofi #FR0000127771
    europesays.com/france/65016/

  24. EC begins antitrust probe into Sanofi’s flu shot campaign

    Nine months after raiding the offices of Sanofi in an unannounced inspection, the European Commission says it has started…
    #France #FR #Europe #EU #Sanofi #Antitrust #CSL #EuropeanCommission #FiercePharmaHomepage #fluvaccine #fluad #Fluzone #marketing #marketinginvestigation #pharma #Seqirus
    europesays.com/france/64783/

  25. Resilient Sanofi stock edges higher as Q2 2026 growth and R&D reshuffle shape outlook

    Sanofi (FR0000127771) stock is holding slightly above its recent levels as investors digest a mix of solid second…
    #France #FR #Europe #EU #Sanofi #FR0000127771
    europesays.com/france/64751/

  26. After FDA delay, Sanofi scores subcutaneous OBI nod for Sarclisa

    Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential…
    #France #FR #Europe #EU #Sanofi #Darzalex #FiercePharmaHomepage #Johnson&Johnson #pharma #Sarclisa #subcutaneousdrugdelivery
    europesays.com/france/64722/

  27. Sanofi (ENXTPA:SAN) Wins Two Drug Approvals In Japan And The EU

    Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi secured approval in Japan for Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia. Cenrifki (tolebr…
    #Japan #JP #JapanNews #immunethrombocytopenia #marketedproducts #news #Sanofi
    alojapan.com/1502797/sanofi-en

  28. alojapan.com/1502797/sanofi-en Sanofi (ENXTPA:SAN) Wins Two Drug Approvals In Japan And The EU #ImmuneThrombocytopenia #Japan #JapanNews #MarketedProducts #news #Sanofi Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi secured approval in Japan for Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia. Cenrifki (tolebrutinib) received EU approval for progressive mu

  29. #news ⚡ Sanofi offen für moderate Erhöhung des Herstellerabschlags: Sanofi-Deutschlandchefin Heidrun Irschik-Hadjieff zeigt sich offen für eine moderate Erhöhung des Herstellerabschlags auf verschreibun... hubu.de/?p=331580 | #erhoehung #herstellerabschlags #sanofi #hubu

  30. #news ⚡ Sanofi offen für moderate Erhöhung des Herstellerabschlags: Sanofi-Deutschlandchefin Heidrun Irschik-Hadjieff zeigt sich offen für eine moderate Erhöhung des Herstellerabschlags auf verschreibun... hubu.de/?p=331580 | #erhoehung #herstellerabschlags #sanofi #hubu

  31. 3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery

    Some investors have watched their healthcare stock holdings drop in value recently or over the years, yet they…
    #NewsBeep #News #Healthcare #AU #Australia #Bristol #Bristol-MyersSquibb #Health #Medtronic #Sanofi #stockholdings #stockprice
    newsbeep.com/au/631162/

  32. #Airbus, #BNP, #Sanofi, #Zara#MoniqueBarbut fr.wikipedia.org/wiki/Monique_ ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises

    Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. vert.eco/articles/airbus-bnp-s

    #politique #info #information #actu #actualite

  33. #Airbus, #BNP, #Sanofi, #Zara#MoniqueBarbut fr.wikipedia.org/wiki/Monique_ ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises

    Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. vert.eco/articles/airbus-bnp-s

    #politique #info #information #actu #actualite

  34. #Airbus, #BNP, #Sanofi, #Zara#MoniqueBarbut fr.wikipedia.org/wiki/Monique_ ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises

    Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. vert.eco/articles/airbus-bnp-s

    #politique #info #information #actu #actualite

  35. Global drug makers face pricing pressure as China targets affordable healthcare

    Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
    newsbeep.com/us/571163/

  36. Sanofi ousts CEO after stalled turnaround at vaccine giant

    French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

    fllics.com/en/video/sanofi-ous

  37. Sanofi ousts CEO after stalled turnaround at vaccine giant

    French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

    fllics.com/en/video/sanofi-ous

  38. Sanofi ousts CEO after stalled turnaround at vaccine giant

    French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

    fllics.com/en/video/sanofi-ous

  39. Sanofi ousts CEO after stalled turnaround at vaccine giant

    French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

    fllics.com/en/video/sanofi-ous

  40. Sanofi ousts CEO after stalled turnaround at vaccine giant

    French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

    fllics.com/en/video/sanofi-ous

  41. Sanofi ousts CEO after stalled turnaround at vaccine giant

    French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

    fllics.com/en/video/sanofi-ous

  42. Sanofi ousts CEO after stalled turnaround at vaccine giant

    French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

    fllics.com/en/video/sanofi-ous

  43. Sanofi ousts CEO after stalled turnaround at vaccine giant

    French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

    fllics.com/en/video/sanofi-ous

  44. Sanofi hợp tác cùng Long Châu khởi động dự án “Thu gom & Tái chế nhựa từ vỉ thuốc vì tương lai xanh”, tập trung thu gom, xử lý và tái chế nhựa để giảm ô nhiễm và xây dựng thói quen bền vững trong cộng đồng. 🌱♻️

    #Sanofi #LongChau #Sustainability #GreenFuture #ThuGom #TaiChe #PlasticRecycling #bảnvững #tươnglaixanh

    vtcnews.vn/sanofi-va-long-chau

  45. Sanofi kauft sich mit 2,56 Mrd. US-Dollar in die Zukunft der Medizin ein. Start-ups wie Earendil Labs wechseln von der bloßen Strukturvorhersage zur aktiven Konstruktion von Antikörpern mittels generativer KI. Parallel entwickelt das MIT KI-basierte Nanopartikel für die Krebsfrüherkennung. Die Ära des physischen Ausprobierens im Labor endet. Ist das der technologische Durchbruch oder ein gefährlicher Hype? #Sanofi #EarendilLabs #Pegasus
    all-ai.de/news/news26/kuenstli

  46. Sanofi kauft sich mit 2,56 Mrd. US-Dollar in die Zukunft der Medizin ein. Start-ups wie Earendil Labs wechseln von der bloßen Strukturvorhersage zur aktiven Konstruktion von Antikörpern mittels generativer KI. Parallel entwickelt das MIT KI-basierte Nanopartikel für die Krebsfrüherkennung. Die Ära des physischen Ausprobierens im Labor endet. Ist das der technologische Durchbruch oder ein gefährlicher Hype? #Sanofi #EarendilLabs #Pegasus
    all-ai.de/news/news26/kuenstli

  47. Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".

    #MECFS #PAIS #Forschung

    Zum Live-Stream: bundestag.de/mediathek/live

  48. Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".

    #MECFS #PAIS #Forschung

    Zum Live-Stream: bundestag.de/mediathek/live

  49. Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".

    #MECFS #PAIS #Forschung

    Zum Live-Stream: bundestag.de/mediathek/live

  50. Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".

    #MECFS #PAIS #Forschung

    Zum Live-Stream: bundestag.de/mediathek/live

  51. Who’s Out? ❌

    #Merck, #Ipsen, #Sanofi and #GSK fall short overall.

    Not good enough companies to be compelling for the next stage.

    If you think any deserved a place, let me know!

    (4/5)